The Lower Drug Costs Now Act and Pharmaceutical Innovation
![Lower Drug](https://www.ohe.org/wp-content/uploads/2021/11/Lower-Drug-150x150.png)
Value-Based Pricing (VBP) aligns the price of a treatment with the value it provides to patients, healthcare systems, and society. Across multiple indications, a single price may not accurately reflect a medicine’s value, Indication-Based Pricing (IBP) allows different prices to be set for different indications.